Principles of risk assessment

As previously mentioned, GM crops have a number of potential benefits for growers, processors and eventually the consumer, but it is also recognized that there are likely to be environmental impacts and implications for food quality and safety. For example, exploitation of novel GM pest-, disease- and herbicide resistant crops will require different (often reduced) pesticide and herbicide applications. These modified management systems will have an impact upon current agricultural systems and the agricultural environment. Such impacts are best analyzed by risk assessments.

The basic concepts of risk assessment for genetically modified crops are similar to those applied to chemical pesticides where the risk is equal to the frequency and the hazard. For example no exposure (frequency) would equate to zero hazard. Risk assessments study both the severity and extent of the hazard or damage as well as the likelihood and frequency at which the damage will occur. Risk is defined as:
    Risk (impact)= Frequency (exposure) × Hazard

Clearly the ideal situation would be one of zero risk. Since in reality the likelihood of risk is always greater than zero, acceptable risk levels for GM crops must be defined, as with all new technology. What is defined as acceptable is based upon cultural values and may well differ globally. Indeed the current climate of controversy surrounding GM crops signifies strong cultural differences between European and North American consumers in what is defined as acceptable levels of risk for the utilisation of GM crops.

While there are differences in the regulatory procedures controlling the development and commercialisation of GM crops in North America and Europe, both systems apply the same broad principles to assessing the safety of GM crop usage for food, animal feed and in terms of environmental impact. The first step involves thoroughly assessing the procedure for modifying the plant tissue. In the UK, for example, the Advisory Committee on Genetic Modification (ACGM) is the regulatory authority responsible for contained use evaluation; that is, the initial experimental work ‘contained’ within the laboratory or glasshouse. The risk evaluation procedure must be specific to each product. Broadly drawn conclusions, for example based on inter-species comparisons, are unacceptable. Most importantly the information requested in a risk assessment must be derived scientifically, with experiments designed to provide clear, interpretable, unequivocal and reproducible results. A recent addition to the risk-assessment procedure has occurred in the UK, in response to public pressure, where there is now a move towards assessing the societal and cultural impacts of this new technology alongside the environmental and human health risks.

Risk assessment can be divided into four steps (Nickson and McKee 1998):
  1. problem formulation
  2. risk analysis
  3. risk characterisation
  4. risk management.

Problem formulation requires that all available information concerning the plant, the trait and the experimental information is gathered in the context of the most likely hazards, such as toxicity/allergenicity. Once all the data are available, they can be analysed for characterisation of the likelihood and/or severity of the risk. In the final phase of the assessment procedure, the acceptability or otherwise of the identified risk must be determined and effective plans set out for its management. The risk assessment procedure is an iterative one and must continue throughout the use of the product, including post-market monitoring.

In the case of GM crops there are a number of variables/risk types to consider including impacts on the agricultural environment, closely related species, insects and animals and human health. To analyse the consequences of GM crop impact upon the agricultural environment requires a detailed understanding of the characteristics of the GM crop in question. This involves determining which wild relative, if any, it may hybridize with and studying the management systems involved in growing the GM crop itself. It also involves recognising any potential effects on other GM or non-GM crops which are likely to be grown in rotation with the variety being assessed. As an example, GM herbicide tolerant (HT) crops will be treated with different herbicides, with different activity spectra, at different crop development stages, leading to effects on the botanical diversity in the GM-HT crop which are the product of the interaction between the GM crop and the herbicide treatment.

The nature of any hazard is dependent upon the characteristics of both the crop that is modified and of the GM trait. Risk assessments require measurement and study of the hazard or impact of both. Numerous studies have concentrated on measuring frequency phenomena such as gene flow and inter-specific hybridisation without considering the impact of the transgene when it has dispersed or introgressed into other populations or species. In addition the impact of the release of the GM plant will depend on the type and location of the environment into which it is being released. To be truly effective, risk assessments may have to be carried out for a range of locations as they are not necessarily transferable from one site, area, region or country to another.